Jump Financial’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-47,356
Closed -$368K 1617
2024
Q3
$368K Buy
47,356
+23,778
+101% +$172K 0.01% 1220
2024
Q2
$143K Sell
23,578
-30,769
-57% -$190K ﹤0.01% 1606
2024
Q1
$319K Sell
54,347
-14,785
-21% -$87.8K 0.01% 1425
2023
Q4
$542K Sell
69,132
-48,948
-41% -$339K 0.02% 1012
2023
Q3
$863K Buy
118,080
+66,590
+129% +$554K 0.03% 749
2023
Q2
$537K Buy
51,490
+26,990
+110% +$260K 0.02% 994
2023
Q1
$253K Sell
24,500
-4,400
-15% -$56.3K 0.01% 1198
2022
Q4
$398K Buy
28,900
+15,836
+121% +$220K 0.02% 880
2022
Q3
$267K Buy
+13,064
New +$287K 0.01% 1203
2022
Q1
Sell
-22,400
Closed -$618K 1523
2021
Q4
$618K Buy
+22,400
New +$618K 0.04% 563

Other funds holding ANGO

Jump Financial's ANGO Position: Q4 2024 in Review

Jump Financial sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 47,356 shares — an estimated $368K sold.

Jump Financial first reported a position in ANGO in Q4 2021 and held it in 10 quarters. The position peaked at $863K in Q3 2023. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • Jump Financial reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • Jump Financial sold 47,356 AngioDynamics shares in Q4 2024, an estimated $368K.
  • Jump Financial first reported a position in AngioDynamics in Q4 2021 and held it in 10 quarters.
  • Jump Financial's AngioDynamics position peaked at $863K in Q3 2023.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.